OM Outset Medical (OM) Q2 FY26 earnings call
Outset Medical delivered a solid second quarter, driven by strong console sales and a significant refresh agreement with HCA Healthcare, which enhances future revenue visibility. Despite a decline in consumable revenue against tough prior-year comparables, the company demonstrated strong gross margin expansion and disciplined cash management. Management is focused on scaling its commercial engine and leveraging new growth tailwinds, including the refresh cycle and the upcoming NextGen Tableau launch, to drive future adoption and profitability.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.